The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 15, 2026
Filed:
Feb. 05, 2024
Applicant:
Zevra Therapeutics, Inc., Celebration, FL (US);
Inventors:
Sven Guenther, Coralville, IA (US);
Guochen Chi, Coralville, IA (US);
Travis Mickle, Kissimme, FL (US);
Assignee:
Zevra Therapeutics, Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4425 (2006.01); A61K 9/00 (2006.01); A61K 31/4458 (2006.01); A61K 31/4545 (2006.01); A61K 47/55 (2017.01); C07D 213/79 (2006.01); C07D 213/80 (2006.01); C07D 213/81 (2006.01); C07D 401/06 (2006.01); C07D 413/06 (2006.01); A61K 9/02 (2006.01);
U.S. Cl.
CPC ...
C07D 213/79 (2013.01); A61K 9/0019 (2013.01); A61K 9/0043 (2013.01); A61K 31/4458 (2013.01); A61K 31/4545 (2013.01); A61K 47/55 (2017.08); C07D 213/80 (2013.01); C07D 213/81 (2013.01); C07D 401/06 (2013.01); C07D 413/06 (2013.01); A61K 9/0053 (2013.01); A61K 9/02 (2013.01);
Abstract
Discloses are d-amphetamine compounds and compositions comprising at least on organic acid covalently bound to d-amphetamine, having the structure of Formula I, a salt thereof, a derivative thereof, or a combination thereof. Methods of making and using the same are also disclosed.